Dentists in N Miami, FL Accepting Medicare
2 Dentists found. Showing 1 - 2
 Mrs. Margot Denise Jobson Poux, DDS Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 1245 Nw 119th Street, N Miami, FL 33167 Phone: 305-685-7863 Fax: 305-687-7603 |
 Paul Theodore Richman, DDS Dentist - Oral and Maxillofacial Pathology Medicare: Not Enrolled in Medicare Practice Location: 1045 Ne 125th St, N Miami, FL 33161 Phone: 305-891-3306 Fax: 305-891-4476 |
News Archive
Calcium channel blocker reduces adverse cardiovascular events
The calcium channel blocker amlodipine decreases the risk of cardiovascular events (such as heart attack or heart-disease related deaths) in patients with coronary artery disease and normal blood pressure, as does the ACE inhibitor enalapril, but to a lesser extent, according to a study in the November 10 issue of JAMA.
N95 respirators designed for single use can be decontaminated effectively
N95 respirators, which are widely worn by health care workers treating patients with COVID-19 and are designed to be used only once, can be decontaminated effectively and used up to three times, according to research by UCLA scientists and colleagues.
There may be a real code to chromosomal organization
The identification of a cluster of essential genes on mouse chromosome 11 as well as similar clusters on the chromosomes of other organisms , including humans , buttresses the argument that there may be rules as to how genes are structured or laid out on chromosomes, said the Baylor College of Medicine senior author of a report that appears online in the Public Library of Science Genetics, an open-access publication.
'Classic doctoring' still has big role to play in diagnosis, treatment of neurocutaneous syndromes
A pair of neurologists at Nationwide Children's Hospital, Monica P. Islam, MD, and E. Steve Roach, MD, are the editors behind "Neurocutaneous Syndromes," a recently published book that highlights the insights of neurocutaneous syndromes research and shows that "classic doctoring" still has a big role to play in diagnosis and treatment.
COPD phase III study by Almirall and Forest Laboratories announces positive results
Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall's inhaler Genuair® (Pressair™ in the USA).
› Verified 2 days ago